Indoleamine 2,3-dioxygenase activity during I131-radioisotope therapy for metastatic thyroid cancer

Kenichi Sakurai, Shigeru Fujisaki, Keita Adachi, Shuhel Suzuki, Yuki Masuo, Saki Nagashima, Yukiko Hara, Ryouichi Tomita, Kenji Gonda, Tomohiro Hirano, Katsuhisa Enomoto

研究成果: ジャーナルへの寄稿記事査読

1 被引用数 (Scopus)

抄録

We evaluated the clinical significance of indoleamine 2,3-dioxygenase (IDa) during I131-radioisotope therapy for metastatic thyroid cancer. The IDO activity can be measured by the tryptophan (Trp)/kynurenine (Kyn) ratio. Trp and Kyn were measured by using high performance liquid chromatography (HPLC). The serum Trp/Kyn levels of were lower in thyroid cancer patients with lung metastases than in patients without metastases. The IDO activity increased after the development of lung metastases from thyroid cancer. The DO activity was correlated with the number of metastatic lesions during I131-radio- isotope therapy. These results suggest that measurement of the Trp/Kyn ratio is useful in the evaluation of the immunological metastatic status during I131-radioisotope therapy.

本文言語英語
ページ(範囲)1259-1261
ページ数3
ジャーナルJapanese Journal of Cancer and Chemotherapy
42
10
出版ステータス出版済み - 10月 2015

フィンガープリント

「Indoleamine 2,3-dioxygenase activity during I131-radioisotope therapy for metastatic thyroid cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル